Large quantities of eggs are used in various manufacturing and processing industries, particularly in the pharmaceutical and biotech industries. These eggs must often be decapped for vaccine production or capsule filling process. Many existing decapping methods and devices are being adopted by the processing industries such as pharmaceutical and biotech. The Embrex Vaccine Egg Decapper (VED) from Zoetis is a semi-automated device that removes the tops of embryonated chicken eggs intended for vaccine production. The egg decapper utilizes a proprietary cutting and cleaning system that helps facilitate a clean cut and deposits shells into a waste container assisting in minimizing shell debris. Such mobile devices are ideal for small production and laboratory research facilities. Further, the Embrex egg decapper is specialized in decapping 36 or 42 eggs simultaneously, with a throughput efficiency of 5,000 to 18,000 eggs per hour with a human-machine interface (HMI) and programmable logic controller (PLC) for full system control. Therefore, once the egg decapper process is performed the specimen is collected in the tubes for further processing. Such advanced decapping technology in the process industry for specimen collection tubes accelerates the demand for decapping eggs, enhancing overall market growth.
The North America decapping system market is segmented into the US, Canada, and Mexico. The market growth in the region is attributed to the increasing demand for sampling facilities and rising demand for biopharmaceutical tubing that requires automated time-saving cappers and decappers. Moreover, due to the expansion of the pharmaceutical & biopharmaceutical industry in the region, the demand for decapping systems is growing.
Strategic insights for the North America Decapping System provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the North America Decapping System refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.North America Decapping System Strategic Insights
North America Decapping System Report Scope
Report Attribute
Details
Market size in 2022
US$ 137.19 Million
Market Size by 2028
US$ 184.42 Million
Global CAGR (2022 - 2028)
5.1%
Historical Data
2020-2021
Forecast period
2023-2028
Segments Covered
By Type
By Application
By End User
Regions and Countries Covered
North America
Market leaders and key company profiles
North America Decapping System Regional Insights
North America Decapping System Market Segmentation
The North America decapping system market is segmented into type, application, end user, and country.
Based on type, the North America decapping system market is segmented into manual, semi-automated, and automated. The automated segment held the largest share of the North America decapping system market in 2022.
Based on application, the North America decapping system market is segmented into tubes and vials. The tubes segment held a larger share of the North America decapping system market in 2022.
Based on end user, the North America decapping system market is segmented into pharmaceutical and biotech industry, CDMOs/CROs, and others. The pharmaceutical and biotech industry segment held the largest share of the North America decapping system market in 2022.
Based on country, the North America decapping system market is segmented into the US, Canada, and Mexico. The US dominated the North America decapping system market in 2022.
Agilent Technologies Inc, Azenta Inc, Cole-Parmer Instrument Co LLC, Hamilton Co, Micronic Holding BV, Sarstedt AG and Co KG, and Thermo Fisher Scientific Inc are some of the leading companies operating in the North America decapping system market.
The North America Decapping System Market is valued at US$ 137.19 Million in 2022, it is projected to reach US$ 184.42 Million by 2028.
As per our report North America Decapping System Market, the market size is valued at US$ 137.19 Million in 2022, projecting it to reach US$ 184.42 Million by 2028. This translates to a CAGR of approximately 5.1% during the forecast period.
The North America Decapping System Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Decapping System Market report:
The North America Decapping System Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Decapping System Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Decapping System Market value chain can benefit from the information contained in a comprehensive market report.